|Bid||11.90 x 900|
|Ask||12.55 x 2200|
|Day's Range||11.87 - 12.68|
|52 Week Range||6.35 - 18.00|
|Beta (5Y Monthly)||2.18|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 11, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Aug 28, 1996|
|1y Target Est||23.00|
We feel now is a pretty good time to analyse CEL-SCI Corporation's (NYSEMKT:CVM) business as it appears the company...
CEL-SCI awarded European patent for LEAPS Vaccine in treatment of Rheumatoid Arthritis.
CEL-SCI Corporation issues letter to shareholders.